Hangzhou Eli Radiopharma Co., Ltd.
PrivateLast Round
VC Round
Mar 12, 2026
Total Funding Raised
$27.76M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Hangzhou Eli Radiopharma Co., Ltd. is a pharmaceutical company that develops targeted radiopharmaceuticals for the diagnosis and treatment of oncology and neurological diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Imaging, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hangzhou Eli Radiopharma Co., Ltd. Comparables
Compare Hangzhou Eli Radiopharma Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Boomray Pharmaceuticals Co., Ltd. | 86% | |
| AlphaGen Therapeutics | 86% | |
| C-Ray Therapeutics | 85% |
Hangzhou Eli Radiopharma Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Mar 12, 2026 | ||||
| Angel | Sep 25, 2025 | ||||
| Angel | Dec 24, 2024 |
Hangzhou Eli Radiopharma Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KHK & Partners | Angel |
| BioClub | VC Round |
| YuanBio Venture Capital | Angel |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 12, 2026
$15M round led by BioClub.
- Sep 25, 2025
$14M raised from KHK & Partners.
Hangzhou Eli Radiopharma Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Hangzhou Eli Radiopharma Co., Ltd.'s valuation, stock price, and market status.
Is Hangzhou Eli Radiopharma Co., Ltd. a public or private company?
Hangzhou Eli Radiopharma Co., Ltd. is a private company.
What is the current stock price of Hangzhou Eli Radiopharma Co., Ltd.?
Hangzhou Eli Radiopharma Co., Ltd. is a private company with no public stock price. Caplight tracks Hangzhou Eli Radiopharma Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Hangzhou Eli Radiopharma Co., Ltd. worth (valuation)?
Valuation information for Hangzhou Eli Radiopharma Co., Ltd. is not publicly available.
Can I buy Hangzhou Eli Radiopharma Co., Ltd. stock?
Hangzhou Eli Radiopharma Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Hangzhou Eli Radiopharma Co., Ltd.'s last funding round?
Hangzhou Eli Radiopharma Co., Ltd.'s most recent funding round was VC Round on March 12, 2026.
Who are the main investors in Hangzhou Eli Radiopharma Co., Ltd.?
Key investors in Hangzhou Eli Radiopharma Co., Ltd. include KHK & Partners, BioClub, YuanBio Venture Capital.
Will Hangzhou Eli Radiopharma Co., Ltd. IPO soon?
No public IPO plans have been announced for Hangzhou Eli Radiopharma Co., Ltd..
How can I track Hangzhou Eli Radiopharma Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Hangzhou Eli Radiopharma Co., Ltd.'s secondary market activity and sign up for updates.